From the Editor:
July/August 2012 Issue (Volume 21, Number 4)
The July-August issue of Cardiovascular Pathology reflects the felicitous, symbiotic relationship between the Society for Cardiovascular Pathology (SCVP) and the society-sponsored journal, Cardiovascular Pathology. The evidence is shown by the three lead articles:
1) Professor Gaetano Thiene's SCVP Distinguished Achievement Award presentation - Arrythmogenic cardiomyopathy: from autopsy to genes and transgenic mice;
2) An insightful review article by Dr. Marc Halushka - Single gene disorders of the aortic wall; and
3) Consensus statement on endomyocardial biopsy from the European Association for Cardiovascular Pathology and the Society for Cardiovascular Pathology.
The July-August issue contains 136 pages of print versus the usual 64 pages as we continue to take advantage of the generous offer of our Elsevier publisher, David Sampson, to publish an increased number of pages this year in order to reduce the backlog of accepted papers. As a result we are publishing papers accepted through the end of November 2011. A summary of the full content is as follows:
Finally, I again want to highlight the good news that the 2011 impact factor for our Society journal, Cardiovascular Pathology, was 2.066. This is the first time to see our impact factor over 2. This is a landmark for our bimonthly journal and reflects well on the discriminating work of our former editors, Dr Jack Butany and Dr Avrum Gotlieb, building on the work of the founding editor, Dr. Stephen Factor, the editorial board and reviewers, as well as the contributions of the authors themselves.
Total articles published in 2010 = 113
Cites to articles published in 2010 = 219 Impact Factor = 2.066
I join our previous editors and our Publications Committee chair, Dr. Fred Schoen, in thanking everyone for their work as editorial board members and reviewers, and in expressing the expectation that we can move the impact factor toward 3.0 especially if society members submit some of their best work for publication in CVP.
L. Maximilian Buja, M.D.